Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A43603 | 31310401 | Liver Int | Author response to Letter to the Editor: "Statins and non-alcoholic fatty liver disease". | 2019 | Details |
| A43604 | 31301829 | J Dairy Sci | Invited review: Sphingolipid biology in the dairy cow: The emerging role of ceramide. | 2019 | Details |
| A43605 | 31301336 | Metabolism | Effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Ex quo et quo vadimus? | 2019 | Details |
| A43606 | 31301077 | Hepatology | Obesity and Liver Disease: The New Era of Liver Transplantation. | 2019 | Details |
| A43607 | 31300671 | Sci Rep | Insulin resistance and metabonomics analysis of fatty liver haemorrhagic syndrome in laying hens induced by a high-energy low-protein diet. | 2019 | Details |
| A43608 | 31300372 | Clin Res Hepatol Gastroenterol | Pharmacological treatments of the "Fibrotic-NASH": Towards a delivery on time? | 2019 | Details |
| A43609 | 31298746 | Hepatology | Changing NAFLD Epidemiology in China. | 2019 | Details |
| A43610 | 31296380 | Biochem Biophys Res Commun | Spinal miR-34a regulates inflammatory pain by targeting SIRT1 in complete Freund's adjuvant mice. | 2019 | Details |
| A43611 | 31294797 | J Burn Care Res | The Influence of Obesity on Treatment and Outcome of Severely Burned Patients. | 2019 | Details |
| A43612 | 31291637 | Med Princ Pract | Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease. | 2019 | Details |
| A43613 | 31290314 | J Proteome Res | Lipidomics Reveals Similar Changes in Serum Phospholipid Signatures of Overweight and Obese Pediatric Subjects. | 2019 | Details |
| A43614 | 31288553 | Angiology | NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity? | 2019 | Details |
| A43615 | 31284360 | Gut Liver | Nonalcoholic Fatty Liver Disease Is a Stepping Stone in the Path toward Diabetes Mellitus. | 2019 | Details |
| A43616 | 31282740 | Am J Physiol Endocrinol Metab | Copper deficiency can change the microbiome of swine. | 2019 | Details |
| A43617 | 31282739 | Am J Physiol Endocrinol Metab | Reply to Letter to the Editor: "Copper deficiency can change the microbiome of swine". | 2019 | Details |
| A43618 | 31280512 | Isr Med Assoc J | Recurrent Urinary Tract Infection: Time to Recommend Weight Loss? | 2019 | Details |
| A43619 | 31278577 | Eur Radiol | Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis. | 2019 | Details |
| A43620 | 31273795 | Hepatology | Fructose Promotion of Intestinal and Liver Injury: A Sugar by Any Other Name That Isn't So Sweet. | 2019 | Details |
| A43621 | 31269936 | BMC Med | Assessing the disease burden of non-alcoholic fatty liver disease in the real world - big data and big numbers. | 2019 | Details |
| A43622 | 31267040 | Nat Rev Gastroenterol Hepatol | Organoid modelling of NAFLD. | 2019 | Details |
| A43623 | 31264285 | J Cell Biochem | Effect of oleic acid on induction of steatosis and cytotoxicity in BRL 3A cells. | 2019 | Details |
| A43624 | 31263357 | Ann Gastroenterol | Rheumatologic manifestations of hepatic diseases. | 2019 | Details |
| A43625 | 31260576 | Hepatol Res | Branched chain amino acids: A factor for zone 3 steatosis in non-alcoholic fatty liver disease. | 2019 | Details |
| A43626 | 31260111 | J Inherit Metab Dis | Chronic liver involvement in urea cycle disorders. | 2019 | Details |
| A43627 | 31258478 | Front Pharmacol | Therapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review. | 2019 | Details |
| A43628 | 31253430 | J Pharmacol Sci | A novel AMPK activator improves hepatic lipid metabolism and leukocyte trafficking in experimental hepatic steatosis. | 2019 | Details |
| A43629 | 31252189 | Clin Gastroenterol Hepatol | Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug. | 2019 | Details |
| A43630 | 31248299 | Expert Rev Gastroenterol Hepatol | Validation of the chronic liver disease questionnaire for non-alcoholic steatohepatitis in patients: impact for the clinic. | 2019 | Details |
| A43631 | 31245423 | Hepatobiliary Surg Nutr | Alcohol consumption in non-alcoholic fatty liver disease-harmful or beneficial? | 2019 | Details |
| A43632 | 31245415 | Hepatobiliary Surg Nutr | What will happen in patients with advanced nonalcoholic fatty liver disease? | 2019 | Details |
| A43633 | 31245411 | Hepatobiliary Surg Nutr | Paediatric non-alcoholic fatty liver disease: a more complex disease than in the adulthood? | 2019 | Details |
| A43634 | 31245408 | Hepatobiliary Surg Nutr | Diet quality and nonalcoholic fatty liver disease. | 2019 | Details |
| A43635 | 31245407 | Hepatobiliary Surg Nutr | Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association. | 2019 | Details |
| A43636 | 31240235 | Hypoxia (Auckl) | Role of pseudohypoxia in the pathogenesis of type 2 diabetes. | 2019 | Details |
| A43637 | 31237636 | JAMA | Low Free Sugar Diet in Adolescents With Nonalcoholic Fatty Liver Disease-Reply. | 2019 | Details |
| A43638 | 31237631 | JAMA | Low Free Sugar Diet in Adolescents With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43639 | 31237448 | Am J Physiol Endocrinol Metab | Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes. | 2019 | Details |
| A43640 | 31234250 | Clin Mol Hepatol | Carnitine palmitoyl transferase 1A deficiency in an adult with recurrent severe steato hepatitis aggravated by high pathologic or physiologic demands: A roller-coaster for internists. | 2019 | Details |
| A43641 | 31229271 | J Hepatol | Liver transplantation for non-alcoholic steatohepatitis in Europe: Where do we stand? | 2019 | Details |
| A43642 | 31229270 | J Hepatol | Referral pathways for NAFLD fibrosis in primary care - No longer a 'needle in a haystack'. | 2019 | Details |
| A43643 | 31227258 | J Hepatol | Hepatic fat: Pathogenic trigger or passenger? | 2019 | Details |
| A43644 | 31225877 | J Clin Endocrinol Metab | Letter to the Editor: "Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content". | 2019 | Details |
| A43645 | 31225873 | J Clin Endocrinol Metab | Response to Letter to the Editor: "Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content". | 2019 | Details |
| A43646 | 31225638 | Br J Dermatol | Management of psoriasis as a systemic disease: what is the evidence? | 2019 | Details |
| A43647 | 31220350 | Hepatology | Considering the Links Between Nonalcoholic Fatty Liver Disease and Insulin Resistance: Revisiting the Role of Protein Kinase C ε. | 2019 | Details |
| A43648 | 31213365 | J Hepatol | Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers. | 2019 | Details |
| A43649 | 31201689 | J Nucl Cardiol | Non-alcoholic fatty liver disease and coronary atherosclerosis-does myocardial glucose metabolism provide the missing link? | 2019 | Details |
| A43650 | 31200402 | Klin Lab Diagn | [Insulin resistance is an alimentary deficiency of energy substrates (glucose) in the biological reaction of exotrophy and aphysiology compensation by fatty acids via the biological reaction of endothrophy.] | 2019 | Details |
| A43651 | 31197261 | Nat Rev Gastroenterol Hepatol | The diagnosis of nonalcoholic fatty liver disease should carry important prognostic information. | 2019 | Details |
| A43653 | 31185002 | Am J Gastroenterol | Pancreatic Steatosis: An Emerging Clinical Entity. | 2019 | Details |
| A43654 | 31180389 | North Clin Istanb | The relationship between vitamin D level and hepatosteatosis in obese children. | 2018 | Details |
| A43655 | 31172210 | Abdom Radiol (NY) | Measurement of spleen fat on MRI-proton density fat fraction arises from reconstruction of noise. | 2019 | Details |
| A43656 | 31168518 | Hepatol Commun | The Time Is Now for Mandatory Liver-Focused Clinical Experiences in Medical School. | 2019 | Details |
| A43657 | 31168510 | Hepatol Commun | Protective Function of Mitogen-Activated Protein Kinase Phosphatase 5 in Aging- and Diet-Induced Hepatic Steatosis and Steatohepatitis. | 2019 | Details |
| A43658 | 31167890 | Diabetes Care | Fatty Liver Among Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study). | 2019 | Details |
| A43659 | 31167603 | Prog Transplant | Liver Transplantation in a Patient With Anti-Coa Antibodies. | 2019 | Details |
| A43660 | 31162673 | Alcohol Clin Exp Res | Chalcone Derivative L6H21 Reduces EtOH + LPS-Induced Liver Injury Through Inhibition of NLRP3 Inflammasome Activation. | 2019 | Details |
| A43661 | 31162259 | Clin Nucl Med | Rapidly Lethal Ruptured Hepatocellular Carcinoma With Disseminated Peritoneal Carcinomatosis on FDG PET/CT. | 2019 | Details |
| A43662 | 31161724 | Liver Int | Reply to: CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitis. | 2019 | Details |
| A43663 | 31160717 | Cell Death Differ | SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity. | 2019 | Details |
| A43664 | 31158374 | Gastroenterology | Toward More Accurate Nomenclature for Fatty Liver Diseases. | 2019 | Details |
| A43665 | 31152594 | Hepatology | Letter to the Editor: Suggestions for Rational Management of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43666 | 31152591 | Hepatology | Reply. | 2019 | Details |
| A43667 | 31149958 | Eur J Gastroenterol Hepatol | The significance of paired biopsies in estimating disease progression in patients with nonalcoholic steatohepatitis. | 2019 | Details |
| A43668 | 31149289 | Acta Endocrinol (Buchar) | NON-INVASIVE ASSESSMENT OF LIVER STEATOSIS AND FIBROSIS USING TRANSIENT ELASTOGRAPHY AND CONTROLLED ATTENUATION PARAMETER IN TYPE 2 DIABETES PATIENTS. | 2022 | Details |
| A43669 | 31142817 | Nat Rev Gastroenterol Hepatol | Engaging primary care clinicians in the assessment of NAFLD. | 2019 | Details |
| A43670 | 31142103 | Clin Mol Hepatol | Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease. | 2019 | Details |
| A43671 | 31142011 | Int J Mol Sci | Involvement of G-Protein-Coupled Receptor 40 in the Inhibitory Effects of Docosahexaenoic Acid on SREBP1-Mediated Lipogenic Enzyme Expression in Primary Hepatocytes. | 2019 | Details |
| A43672 | 31139353 | Clin Liver Dis (Hoboken) | Nonalcoholic Fatty Liver Disease Risk Factors in Latin American Populations: Current Scenario and Perspectives. | 2019 | Details |
| A43673 | 31137678 | Int J Mol Sci | Adipokinome Signatures in Obese Mouse Models Reflect Adipose Tissue Health and Are Associated with Serum Lipid Composition. | 2019 | Details |
| A43674 | 31134715 | J Viral Hepat | Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B. | 2019 | Details |
| A43675 | 31134632 | Hepatology | Is Trimming the Fat Enough? Fibroblast Growth Factor 21 as An Emerging Treatment for Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43676 | 31132831 | Korean J Gastroenterol | [Hepatobiliary Manifestation of Inflammatory Bowel Disease]. | 2019 | Details |
| A43677 | 31130490 | J Clin Lipidol | Low LDL cholesterol-Friend or foe? | 2019 | Details |
| A43678 | 31121179 | Metabolism | Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction? | 2019 | Details |
| A43679 | 31114057 | Nat Rev Gastroenterol Hepatol | The effects of platelet accumulation in fatty liver disease. | 2019 | Details |
| A43680 | 31110552 | Evid Based Complement Alternat Med | An Overview of the Randomized Placebo-Controlled Trials of Chinese Herbal Medicine Formula Granules. | 2019 | Details |
| A43681 | 31107977 | Hepatology | Macrophage Nourishment in Nonalcoholic Steatohepatitis: A Novel Role for Ketone Bodies. | 2019 | Details |
| A43682 | 31107690 | Am J Gastroenterol | Response to Lai. | 2019 | Details |
| A43683 | 31106419 | J Cell Physiol | Impact of different ectopic fat depots on cardiovascular and metabolic diseases. | 2019 | Details |
| A43684 | 31104878 | Clin Nutr | Reply-Letter to the Editor-Is liver steatosis diagnostic of non-alcoholic fatty liver disease in patients with hereditary fructose intolerance? | 2019 | Details |
| A43685 | 31099070 | Hepatology | Letter to the Editor: Bone Health in Nonalcoholic Fatty Liver Disease: A Mechanistic Insight. | 2019 | Details |
| A43686 | 31098375 | Hepatobiliary Surg Nutr | Economic burden and healthcare utilization in nonalcoholic fatty liver disease. | 2019 | Details |
| A43687 | 31098374 | Hepatobiliary Surg Nutr | Nonalcoholic fatty liver disease in obese adolescents: the role of genetic polymorphisms. | 2019 | Details |
| A43688 | 31098372 | Hepatobiliary Surg Nutr | Building mass to prevent non-alcoholic fatty liver disease? | 2019 | Details |
| A43689 | 31098371 | Hepatobiliary Surg Nutr | Nonalcoholic fatty liver disease with advanced fibrosis as a multi-systemic disease: proceed with caution. | 2019 | Details |
| A43690 | 31098370 | Hepatobiliary Surg Nutr | Nonalcoholic fatty liver disease (NAFLD) prevention: role of Mediterranean diet and physical activity. | 2019 | Details |
| A43691 | 31098369 | Hepatobiliary Surg Nutr | Nonalcoholic fatty liver disease: does sex matter? | 2019 | Details |
| A43692 | 31098363 | Hepatobiliary Surg Nutr | Sarcopenia and nonalcoholic fatty liver disease: a causal relationship. | 2019 | Details |
| A43693 | 31096219 | Ann Nutr Metab | Youth-Onset Type 2 Diabetes Manifestations in other Specialties: Its Many Disguises. | 2019 | Details |
| A43694 | 31094184 | Ter Arkh | Аdеmethionine in the treatment of fatigue in liver diseases: a systematic review. | 2019 | Details |
| A43695 | 31089553 | J Obes Metab Syndr | Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes (J Obes Metab Syndr 2018;27:53-60). | 2018 | Details |
| A43696 | 31089552 | J Obes Metab Syndr | Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes (J Obes Metab Syndr 2018;27:53-60). | 2018 | Details |
| A43697 | 31087779 | IUBMB Life | Intricate role of yes-associated protein1 in human liver cirrhosis: TGF-β1 still is a giant player. | 2019 | Details |
| A43698 | 31084205 | Ann Clin Biochem | The association between lecithin-cholesterol acyltransferase activity and fatty liver index. | 2019 | Details |
| A43700 | 31083812 | Intern Med J | Non-alcoholic fatty liver disease. | 2019 | Details |
| A43701 | 31082344 | Zhonghua Gan Zang Bing Za Zhi | [Effect of high-intensity intermittent exercise on high-fat diet-induced hepatic fat deposition in C57BL/6 mice]. | 2019 | Details |
| A43702 | 31081583 | Liver Int | Statins and non-alcoholic fatty liver disease. | 2019 | Details |
| A43703 | 31080231 | Pol Arch Intern Med | High-sensitivity C-reactive protein as a new predictor of the course of nonalcoholic fatty liver disease in patients after bariatric surgery. | 2019 | Details |
| A43704 | 31078304 | Clin Nutr | Is liver steatosis diagnostic of non-alcoholic fatty liver disease in patients with hereditary fructose intolerance? | 2019 | Details |